Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250520570730/en/ZEVTERA-ceftobiprole-an-Advanced-Generation-Cephalosporin-Antibiotic-Now-Commercially-Available-in-the-U.S.-to-Treat-Three-Types-of-Bacterial-Infections

BUSINESSWIRE
20 May 2025

https://www.globenewswire.com/news-release/2025/04/16/3062270/0/en/Basilea-reports-presentation-of-new-data-for-fosmanogepix-isavuconazole-Cresemba-and-ceftobiprole-Zevtera-at-ESCMID-Global-2025.html

GLOBENEWSWIRE
16 Apr 2025

https://www.globenewswire.com/news-release/2025/01/28/3016062/0/en/Strong-sales-growth-for-Cresemba-and-Zevtera-trigger-further-milestone-payments-to-Basilea.html

GLOBENEWSWIRE
28 Jan 2025

https://www.businesswire.com/news/home/20241216588264/en

BUSINESSWIRE
16 Dec 2024

https://www.globenewswire.com/news-release/2024/05/03/2874833/0/en/Basilea-reports-presentation-of-new-data-for-ceftobiprole-Zevtera-at-ESCMID-Global-2024.html

GLOBENEWSWIRE
03 May 2024

https://www.globenewswire.com//news-release/2023/10/17/2761159/0/en/Basilea-reports-new-data-for-ceftobiprole-Zevtera-presented-at-US-IDWeek-Congress-2023.html

GLOBENEWSWIRE
17 Oct 2023